Mycomedica Life Sciences Pbc

This early-stage study tested multiple doses of MLS101 (a low-dose psilocybin) in 20 healthy volunteers aged 18 to 55. Researchers used brain scans (fMRI) to see how the drug affects brain activity and checked for side effects. The goal was to gather safety and brain-imaging data…